Navigation Links
EntreMed Reports First Quarter 2009 Financial Results
Date:5/6/2009

ROCKVILLE, Md., May 6 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today reported financial results for the three months ended March 31, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

The Company reported a net loss for the first quarter of approximately ($3.5 million), or ($0.04) per share, compared with a net loss of ($8.3 million), or ($0.10) per share, for the same period last year. The Company did not report any revenues for the first quarter 2009. As of March 31, 2009, the Company had cash and short-term investments of approximately $20.8 million.

Kathy R. Wehmeir-Davis, Principal Accounting Officer, commented on the first quarter results, "The Company's first quarter 2009 financial results were in line with our projections. During the first quarter, the Company realized significant cost savings as a result of our strategy to accelerate the clinical development of our priority Aurora A and angiogenic kinase inhibitor, ENMD-2076, and to focus our financial resources primarily on activities that support the advancement of this program. We expect operational expenses to remain at similar levels through the second quarter. Consistent with the past few years, we anticipate recording royalty revenue from Celgene's sales of Thalomid(R) beginning in the third quarter."

Michael M. Tarnow, Executive Chairman commented, "Our first quarter operating results are a testimony to our diligence in streamlining operations and reducing non-essential expenditures. The corpor
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. EntreMed Reports Fourth Quarter and Year-End 2008 Financial Results
2. EntreMed Focuses on Development of ENMD-2076
3. EntreMed Reports Clinical Program Progress and Company Update
4. EntreMed to Present at the Rodman and Renshaw 10th Annual Healthcare Conference
5. EntreMed Teams with JSB-Partners to Expedite Partnering of its Aurora Kinase Program
6. EntreMed to Present at the BIO 2008 Annual International Convention
7. EntreMed to Present at The Rodman and Renshaw 5th Annual Global Healthcare Conference
8. EntreMed Reports First Quarter 2008 Financial Results
9. Dr. Ronald E. Cape to Retire from EntreMed Board of Directors
10. EntreMed to Present at the Jesup & Lamont Emerging Growth Stock Conference
11. EntreMed Announces FDA Acceptance of IND Application for Panzem(R) in Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... At the presentation of the 2015 Annual Meeting of the ... research presented by the Journal of Arthroplasty pertaining to how soon after undergoing hip ... Results of the study confirm what Santa Rosa Orthopaedics (SRO) surgeon Nathan ...
(Date:7/30/2015)... ... July 30, 2015 , ... World Breast-Feeding ... to ensure their children have the nutrition required to grow into healthy adults. ... discount cards for many prescription pre-natal vitamins. , Folic Acid , Arguably one ...
(Date:7/29/2015)... ... July 30, 2015 , ... In their ... approved provider of online continuing education courses for Athletic Trainers , HomeCEUConnection.com, ... Andrews Research and Education Sports Medicine Series. , The new online continuing education ...
(Date:7/29/2015)... ... July 29, 2015 , ... Avatar Solutions has received official ... for PQRS Survey. , The CAHPS for PQRS Survey collects information about ... or more eligible providers must participate or they will receive a 2% penalty in ...
(Date:7/29/2015)... ... July 29, 2015 , ... This past week, CARE Surrogacy ... from a treasured member of the CARE extended family. , By shedding light ... intended parents across the globe gain a newfound perspective on surrogacy in Mexico. The ...
Breaking Medicine News(10 mins):Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 2Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 2Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 4Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 3Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 3Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 3
... Gerontological Society of America (GSA) the nation,s ... has chosen Alan Jette, PhD, of Boston University ... of Aging Persons Award. This distinguished honor is ... of rehabilitation. The awardee,s work may be in any ...
... be used to determine whether a lung cancer patient ... published in the August issue of the Journal ... the International Association for the Study of Lung Cancer ... been found to respond well to crizotinib, an ALK ...
... aero-digestive tract cancers (UADT), especially those of the oral cavity, ... as it has been shown repeatedly that heavy drinkers, in ... alcohol use and cigarette smoking is the key factor in ... distinguished group of scientists from the International Agency for Research ...
... sulfide is a foul-smelling gas with an odor resembling that ... is generally associated with decaying vegetation, sewers and noxious industrial ... it also plays a critical role in protecting blood vessels ... from the University of Texas Medical Branch at Galveston. ...
... (HealthDay News) -- Heart attack survivors who live in ... neighborhoods, a new study finds. Regular exercise after ... of survival, the Israeli researchers noted. In the ... more than 10 years to assess their levels of ...
... over 75 are likely to have at least one abnormal liver ... likely to die from cancer and 17 times more likely to ... of Alimentary Pharmacology and Therapeutics . UK researchers studied ... to an in-depth health assessment. Patients were drawn at random from ...
Cached Medicine News:Health News:Jette to receive GSA's 2011 Excellence in Rehabilitation of Aging Persons Award 2Health News:The effects of smoking and alcohol use on risk of upper aero-digestive cancers 2Health News:Scientists show 'swamp gas' protects blood vessels from complications of diabetes 2Health News:Abnormal liver tests associated with increased death rates in people over 75 2Health News:Abnormal liver tests associated with increased death rates in people over 75 3
(Date:7/29/2015)... July 29, 2015  UBM Canon brings MEDevice San ... Marquis & Marina on September 1-2, 2015, with a ... highlight of the Business Development track will be a ... Types of Investors, featuring Renee Ryan , Vice ... Brent Ahrens , Partner, Canaan Partners; and ...
(Date:7/29/2015)... and CAMBRIDGE, Mass. , July ... ISIS ), the leader in RNA-targeted therapeutics, and ... that The New England Journal of Medicine ... clinical study evaluating volanesorsen (formerly ISIS-APOCIII Rx ) ... triglycerides. This publication follows the December 2014 publication ...
(Date:7/29/2015)... WuXi PharmaTech (Cayman) Inc. (NYSE: WX ... company serving the pharmaceutical, biotechnology and medical device industries, ... the United States , today announced ... of 2015 after the New York Stock Exchange closes ... morning, August 14, 2015 Shanghai time). The earnings release ...
Breaking Medicine Technology:MEDevice San Diego Offers Tips on Securing Financial Backing from Investors 2Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 2Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 3Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 4Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 5Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 6Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 7WuXi PharmaTech Schedules Second-Quarter 2015 Earnings Release 2
... IN JACKSONVILLE AREA , ATLANTA, Oct. 5 On June 10, ... to perform drug testing using an onsite rapid test to qualify ... test devices can provide initial drug test results in less than ... If the initial test indicates a negative result, the testing is ...
... and BEAVERTON, Ore., Oct. 5 The ZigBee® ... a liaison agreement to expand their relationship and ... personal health solutions on low-power local area networks ... checked remotely by families and healthcare providers with ...
Cached Medicine Technology:New Florida Law Allows Use of Instant Drug Tests On the Job Site 2The ZigBee Alliance and Continua Health Alliance Collaborate to Expand Telehealth Capabilities 2The ZigBee Alliance and Continua Health Alliance Collaborate to Expand Telehealth Capabilities 3
Cleveland Bone Cutter #5, 17cm, 6-3/4"...
To elevate, dissect, scrape and apply traction to bone and soft tissue....
Diamond Point Bone Probe with Ortho-Grip® silicone rubber palm style handles and,stainless steel impactor caps....
The AV Plus DX pacing lead is designed for use with the St. Jude Medical Affinity VDR pulse generator. This single-lead pacing system provides reliable pacing therapy with the added benefits of AV sy...
Medicine Products: